Exact Sciences Launches Colorectal Cancer Screening Study

The study of the firm's Cologuard test is expected to include more than 10,000 patients between the ages of 50 and 84 who are at average risk for developing colorectal cancer.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.